pfizer glp 1 pill struggles to catch up to Ozempic, Wegovy with weight-loss ADA '26: Lilly's dominance, Pfizer's

Cirilo, M., Coccia, M.E., Attanasio, M and Fatini, C

Among men, the corresponding prevalence rates of macroprolactinomas and microprolactinomas were 53% and 19%, respectively ( 4 Mechanisms by which hyperprolactinemia may promote obesity Hyperprolactinemia has been repeatedly cited as being associated with weight gain in both clinical observations and experimental studies

Any legitimate exploration of these compounds belongs in properly authorized preclinical or clinical research under oversight, not in self-directed use

Examples of Weekly GLP-1 Medications Semaglutide (Ozempic, Wegovy): Administered once a week